Skip to Main Content
Back to News

Lobbying Update: $25,000 of CARPENTER TECHNOLOGY CORPORATION lobbying was just disclosed

None

$25,000 of CARPENTER TECHNOLOGY CORPORATION lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Funding for Additive Manufacturing Technology"

You can find more data on corporate lobbying on Quiver Quantitative.

CRS Insider Trading Activity

CRS Insider Trades

CRS insiders have traded $CRS stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.

Here’s a breakdown of recent trading of $CRS stock by insiders over the last 6 months:

  • TONY R THENE (President and CEO) has made 0 purchases and 2 sales selling 19,000 shares for an estimated $4,654,838.
  • I MARTIN INGLIS has made 0 purchases and 2 sales selling 9,124 shares for an estimated $2,070,271.
  • JAMES D DEE (SVP, Gen Counsel & Sec) sold 5,000 shares for an estimated $1,175,163
  • ELIZABETH A SOCCI (VP, Contr & Ch Acctg Officer) has made 0 purchases and 5 sales selling 5,000 shares for an estimated $1,010,921.
  • STEVEN E KAROL sold 3,433 shares for an estimated $843,772
  • COLLEEN PRITCHETT sold 1,200 shares for an estimated $279,887
  • ANASTASIOS JOHN HART sold 1,000 shares for an estimated $243,725

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

CRS Hedge Fund Activity

We have seen 307 institutional investors add shares of CRS stock to their portfolio, and 239 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • BLACKROCK, INC. removed 1,556,194 shares (-24.6%) from their portfolio in Q2 2025, for an estimated $430,100,897
  • CASTLE HOOK PARTNERS LP added 1,034,097 shares (+inf%) to their portfolio in Q2 2025, for an estimated $285,803,728
  • SURGOCAP PARTNERS LP removed 686,001 shares (-42.6%) from their portfolio in Q2 2025, for an estimated $189,596,956
  • FMR LLC removed 683,289 shares (-12.5%) from their portfolio in Q2 2025, for an estimated $188,847,413
  • DIMENSIONAL FUND ADVISORS LP removed 561,766 shares (-34.0%) from their portfolio in Q2 2025, for an estimated $155,260,887
  • MORGAN STANLEY added 518,195 shares (+145.1%) to their portfolio in Q2 2025, for an estimated $143,218,734
  • WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC added 487,697 shares (+inf%) to their portfolio in Q2 2025, for an estimated $134,789,696

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CRS Analyst Ratings

Wall Street analysts have issued reports on $CRS in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • JP Morgan issued a "Overweight" rating on 06/17/2025
  • Benchmark issued a "Buy" rating on 06/09/2025

To track analyst ratings and price targets for CRS, check out Quiver Quantitative's $CRS forecast page.

CRS Price Targets

Multiple analysts have issued price targets for $CRS recently. We have seen 2 analysts offer price targets for $CRS in the last 6 months, with a median target of $302.5.

Here are some recent targets:

  • Bennett Moore from JP Morgan set a target price of $305.0 on 06/17/2025
  • Josh Sullivan from Benchmark set a target price of $300.0 on 06/09/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles